In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Guy Harchen, VP Client Strategy at FreeMind Group. He provides an explanation of what non-dilutive funding is and why its so attractive to medical device firms. We also get into his vision of the future of digital health and how it will dramatically change how healthcare functions. His views on the pace of that change, however, are particularly interesting. Specifically, the following questions are addressed.

• What is the FreeMind Group and what do you do?
• What is non-dilutive funding?
• From your perspective, why does digital health matter?
• Is the U.S. government interested in the growth of digital health? Why?
• What do you expect to happen with digital health post-pandemic?

Listen to this episode and see what you think of non-dilutive funding and/or digital health. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at [email protected].

Send us a text

For more medtech news and information, visit https://www.mpomag.com.